Original BC

Original Bio-Cell (Original BC) is a Hungarian biotechnology company specializing in oncology research and the development of therapies based on the Passive Antitumor Defense Mechanism (PADM). Established to advance the scientific discoveries of Dr. Gyula Kulcsár, the company focuses on how specific combinations of endogenous small molecules—including amino acids, vitamins, and nucleosides—can selectively induce apoptosis in cancer cells. Their flagship product, Culevit, is widely used as a dietary supplement for cancer patients, while the company continues to pursue pharmaceutical-grade clinical development. Original BC operates its own research laboratories and collaborates with academic institutions to validate the efficacy of its multi-component mixtures. The company's mission is to provide non-toxic, supportive, and therapeutic options that leverage the body's natural biological surveillance systems.